β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations - Archive ouverte HAL Access content directly
Journal Articles FASEB Journal Year : 2022

β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations

Sara Mccurdy
Robert Shenkar
  • Function : Author
Thomas Moore
  • Function : Author
Rhonda Lightle
  • Function : Author
Miguel‐alejandro Lopez-Ramirez
Issam Awad
  • Function : Author
Not file

Dates and versions

hal-03854432 , version 1 (15-11-2022)

Identifiers

Cite

Sara Mccurdy, Robert Shenkar, Thomas Moore, Rhonda Lightle, Eva Faurobert, et al.. β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations. FASEB Journal, 2022, 36 (12), ⟨10.1096/fj.202200907RR⟩. ⟨hal-03854432⟩

Collections

UGA CNRS
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More